Description
CJC-1295 (No DAC) + Ipamorelin 20mg (10mg + 10mg) is a high-purity, research-grade dual-peptide formulation engineered to examine the physiological synergy between a modified growth hormone-releasing hormone (GHRH 1-29) analogue and a selective growth hormone secretagogue receptor (GHSR-1a) agonist. CJC-1295 (No DAC, also known as Modified GRF 1-29) acts as a rapid-acting GHRH receptor agonist, while Ipamorelin selectively targets the ghrelin/GHSR receptor pathway.
This blend is widely used in laboratory environments to investigate dual-pathway signal transduction, somatotroph responsiveness, and the stimulation of endogenous pulsatile growth hormone secretion. The simultaneous administration of these two distinct pathway agonists allows researchers to study synergistic amplification of insulin-like growth factor 1 (IGF-1) expression, lipolytic pathway regulation, and nitrogen retention dynamics without inducing significant elevations in ACTH, cortisol, or prolactin levels.
Product Specifications:
- Quantity: 20mg total per vial (10mg CJC-1295 No DAC + 10mg Ipamorelin)
- Purity: Research-grade, verified via laboratory testing
- Form: Lyophilised peptide blend
- Storage: Store in a cool, dry environment away from direct light
Intended Use:
This product is intended exclusively for laboratory, academic, and controlled research purposes involving receptor synergy analysis, neuroendocrine signalling studies, and cellular metabolic investigations.
Disclaimer:
All information provided is for scientific, educational, and reference purposes only. This product has not been evaluated or approved by any regulatory authority. It is not intended to diagnose, treat, cure, or prevent any disease, and must not be used for human or animal consumption. The purchaser assumes full responsibility for proper handling, storage, and lawful use in a research setting.
Terms of Sale:
By purchasing CJC-1295 (No DAC) + Ipamorelin 20mg (10mg + 10mg) from Puur Active, you confirm that you are a qualified professional, researcher, or institution with the expertise required to safely handle and study research compounds. Puur Active shall not be held liable for misuse, improper handling, or any consequences arising from unauthorised application of this compound.
There are no reviews yet.